Quality of life, binge eating and sexual function in participants treated for obesity with sustained release naltrexone/bupropion
| Autor: | L Acevedo, Amy Halseth, M Malone, Ken Fujioka, Kye Gilder, Kevin Shan |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
Bupropion
medicine.medical_specialty Nutrition and Dietetics Binge eating business.industry Endocrinology Diabetes and Metabolism 030209 endocrinology & metabolism Discontinuation 03 medical and health sciences 0302 clinical medicine Sexual dysfunction Quality of life Internal medicine Medicine Anxiety 030212 general & internal medicine medicine.symptom Binge Eating Scale business Sexual function medicine.drug |
| Zdroj: | Obesity Science & Practice. 4:141-152 |
| ISSN: | 2055-2238 |
| DOI: | 10.1002/osp4.156 |
| Popis: | Objective This multicenter, randomized, controlled, open-label trial examined weight-related quality of life, control over eating behaviour and sexual function after 26 weeks of treatment with either 32 mg naltrexone sustained release (SR)/360 mg bupropion SR plus a comprehensive lifestyle intervention program (NB + CLI, N = 153) or usual care (UC, N = 89), which included minimal lifestyle intervention. Methods Impact of Weight on Quality of Life-Lite, Binge Eating Scale and Arizona Sexual Experiences Scale were assessed at baseline (BL) and weeks 16 and 26. Results NB + CLI and UC participants lost 9.46 and 0.94% respectively of initial body weight at week 26 (P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text